雷艳文, 丁广成, 秦德华, 郭彦伟, 王海霞, 张剑, . . . 郭文静. (2023). SBRT联合卡瑞利珠单抗和阿帕替尼治疗晚期肝细胞癌的疗效及安全性. 解放军医学杂志, 48(12), 1420-1426. https://doi.org/10.11855/j.issn.0577-7402.1540.2023.0215
Chicago Style (17th ed.) Citation雷艳文, 丁广成, 秦德华, 郭彦伟, 王海霞, 张剑, 陈家富, 罗青竹, and 郭文静. "SBRT联合卡瑞利珠单抗和阿帕替尼治疗晚期肝细胞癌的疗效及安全性." 解放军医学杂志 48, no. 12 (2023): 1420-1426. https://doi.org/10.11855/j.issn.0577-7402.1540.2023.0215.
MLA (9th ed.) Citation雷艳文, et al. "SBRT联合卡瑞利珠单抗和阿帕替尼治疗晚期肝细胞癌的疗效及安全性." 解放军医学杂志, vol. 48, no. 12, 2023, pp. 1420-1426, https://doi.org/10.11855/j.issn.0577-7402.1540.2023.0215.
Warning: These citations may not always be 100% accurate.